REVEN Trademark

Trademark Overview

On Friday, May 8, 2015, a trademark application was filed for REVEN with the United States Patent and Trademark Office. The USPTO has given the REVEN trademark a serial number of 86623712. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 5, 2025. This trademark is owned by Reven Pharmaceuticals, Inc.. The REVEN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development in the fields of cardiovascular disease, vascular therapy, skin conditions, diabetic conditions, cancer, infectious disease, sports enhancement, nerve system disease, brain disease and mitochondrial disease; Pharmaceutical services, namely, the development of pharmaceuticals for the treatment of cardiovascular disease, vascular therapy, skin conditions, diabetic conditions, cancer, infectious disease, sports enhancement, nerve system disease, brain disease and mitochondrial disease
reven

General Information

Serial Number86623712
Word MarkREVEN
Filing DateFriday, May 8, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 5, 2025
Registration Number5686415
Registration DateTuesday, February 26, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 27, 2015

Trademark Statements

Translation of Words in MarkThe wording "REVEN" has no meaning in a foreign language.
Goods and ServicesPharmaceutical research and development in the fields of cardiovascular disease, vascular therapy, skin conditions, diabetic conditions, cancer, infectious disease, sports enhancement, nerve system disease, brain disease and mitochondrial disease; Pharmaceutical services, namely, the development of pharmaceuticals for the treatment of cardiovascular disease, vascular therapy, skin conditions, diabetic conditions, cancer, infectious disease, sports enhancement, nerve system disease, brain disease and mitochondrial disease

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 5, 2025
Primary Code042
First Use Anywhere DateFriday, December 21, 2018
First Use In Commerce DateFriday, December 21, 2018

Trademark Owner History

Party NameReven Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressGolden, CO 80401
Party NameReven Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGolden, CO 80401
Party NameReven Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGolden, CO 80401

Trademark Events

Event DateEvent Description
Friday, August 21, 2015EXAMINERS AMENDMENT -WRITTEN
Tuesday, May 12, 2015NEW APPLICATION ENTERED
Monday, May 18, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 19, 2015ASSIGNED TO EXAMINER
Friday, August 21, 2015EXAMINERS AMENDMENT E-MAILED
Friday, August 21, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, August 21, 2015EXAMINER'S AMENDMENT ENTERED
Friday, August 21, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 16, 2015ASSIGNED TO LIE
Monday, September 21, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 7, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 27, 2015PUBLISHED FOR OPPOSITION
Tuesday, October 27, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 22, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, June 22, 2016SOU TEAS EXTENSION RECEIVED
Wednesday, June 22, 2016SOU EXTENSION 1 FILED
Wednesday, June 22, 2016SOU EXTENSION 1 GRANTED
Friday, June 24, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 22, 2016SOU TEAS EXTENSION RECEIVED
Thursday, December 22, 2016SOU EXTENSION 2 FILED
Thursday, December 22, 2016SOU EXTENSION 2 GRANTED
Saturday, December 24, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 22, 2017SOU TEAS EXTENSION RECEIVED
Thursday, June 22, 2017SOU EXTENSION 3 FILED
Thursday, June 22, 2017SOU EXTENSION 3 GRANTED
Saturday, June 24, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 21, 2017SOU TEAS EXTENSION RECEIVED
Thursday, December 21, 2017SOU EXTENSION 4 FILED
Thursday, December 21, 2017SOU EXTENSION 4 GRANTED
Saturday, December 23, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 22, 2018SOU TEAS EXTENSION RECEIVED
Friday, June 22, 2018SOU EXTENSION 5 FILED
Monday, June 25, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, June 25, 2018SOU EXTENSION 5 GRANTED
Tuesday, June 26, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 24, 2018USE AMENDMENT FILED
Wednesday, December 26, 2018TEAS STATEMENT OF USE RECEIVED
Monday, January 7, 2019STATEMENT OF USE PROCESSING COMPLETE
Friday, September 5, 2025CANCELLED SEC. 8 (6-YR)
Monday, February 26, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, January 23, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, January 24, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, February 26, 2019REGISTERED-PRINCIPAL REGISTER

Related Keywords

reven disease conditions enhancement infectious sports nerve mitochondrial brain system pharmaceutical